Kantzanou Maria, Kostares Evangelos, Kostare Georgia, Papagiannopoulou Evangelia, Kostares Michael, Tsakris Athanasios
Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
Department of Anatomy, Medical School, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
Diseases. 2024 Jul 17;12(7):160. doi: 10.3390/diseases12070160.
Our study seeks to provide a comprehensive assessment of leishmaniasis prevalence among blood donors, employing rigorous methodologies to inform public health initiatives and transfusion safety measures. A thorough literature search was conducted using electronic databases (Medline, Scopus, Web of Science, and Google Scholar) to identify the relevant studies reporting the prevalence of leishmaniasis among blood donors, gathering a wide range of studies encompassing different geographic locations and time periods. The pooled prevalence with a 95% confidence interval (CI) was estimated, and quality assessment, outlier analysis, and influential analysis were performed to ensure the robustness and validity of the findings. Our search and subsequent analyses led to the inclusion of thirty-five studies in our review. Using molecular diagnostic methods, the prevalence was estimated at 2.3% (95% CI 1-3.9%), while serological diagnostic methods indicated a higher prevalence rate of 4.5% (95% CI 2.8-6.7%). Notably, we observed significant heterogeneity among the included studies for each analysis. The observed heterogeneity highlights the need for future research to delve into the factors influencing leishmaniasis prevalence, with prospective and retrospective studies addressing the limitations identified in this review.
我们的研究旨在对献血者中利什曼病的流行情况进行全面评估,采用严谨的方法为公共卫生举措和输血安全措施提供依据。我们使用电子数据库(Medline、Scopus、科学网和谷歌学术)进行了全面的文献检索,以识别报告献血者中利什曼病流行情况的相关研究,收集了涵盖不同地理位置和时间段的广泛研究。估计了合并患病率及其95%置信区间(CI),并进行了质量评估、离群值分析和影响分析,以确保研究结果的稳健性和有效性。我们的检索及后续分析使35项研究被纳入我们的综述。使用分子诊断方法,估计患病率为2.3%(95%CI 1-3.9%),而血清学诊断方法显示患病率较高,为4.5%(9